Top compounds associated with response to OR1F1


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.0089 0.8
mRNA tacedinaline CTRPv2 pan-cancer AAC -0.0089 0.8
mRNA tamatinib CTRPv2 pan-cancer AAC 0.0086 0.8
mRNA fluvastatin CTRPv2 pan-cancer AAC 0.0082 0.8
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.0063 0.8
mRNA BRD-K99584050 CTRPv2 pan-cancer AAC 0.012 0.8
mRNA SN-38 CTRPv2 pan-cancer AAC 0.0081 0.8
mRNA betulinic acid CTRPv2 pan-cancer AAC 0.0084 0.8
mRNA GSK1120212 CTRPv2 pan-cancer AAC 0.011 0.8
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.0077 0.8
Download CSV